Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Hot Flashes 2Breast Neoplasms 2Polycystic Ovary Syndrome 1Insulin Resistance 1Hypomagnesemia 1Colonic Neoplasms 1

Interventions

Trastuzumab 594Paclitaxel 561Cyclophosphamide 545Docetaxel 478Capecitabine 387Letrozole 350Fulvestrant 310Doxorubicin 285Carboplatin 277Tamoxifen 257Anastrozole 219exemestane 211Epirubicin 210Radiotherapy 197Bevacizumab 189pertuzumab 175Gemcitabine 163Vinorelbine 162pembrolizumab 161Lapatinib 161palbociclib 152Exercise 132Fluorouracil 118Albumin-Bound Paclitaxel 116eribulin 108Magnetic Resonance Spectroscopy 108130-nm albumin-bound paclitaxel 107Everolimus 103Taxes 96Cisplatin 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Breast Neoplasms × Magnesium Oxide × Clear all
NCT01439945 2017-04-04

Magnesium Oxide in Treating Postmenopausal Women With Hot Flashes and a History of Breast Cancer

Alliance for Clinical Trials in Oncology

Phase 2 Completed
289 enrolled 13 charts
Breast

Breast Neoplasms, Hot Flashes

NCT01008904 2016-06-21

Magnesium Oxide in Treating Hot Flashes in Menopausal Women With Cancer

Virginia Commonwealth University

Phase 2 Completed
31 enrolled 8 charts
Breast

Breast Neoplasms, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡